Mentice (publ), Gothenburg, a globally recognized leader in simulation solutions for image-guided interventional therapies, announced today the appointment of Frans Venker as its new Chief Executive Officer, effective January 1, 2025. Frans Venker succeeds Göran Malmberg, who has served the company for 17 years and will remain in an advisory role. Göran Malmberg's retirement as CEO was previously announced in May.
With over 25 years of experience in the industry addressing the same or related medical needs and therapies as Mentice, Venker brings a wealth of expertise and a proven track record in driving innovation, operational excellence, and sustainable growth. Most recently, he led the Business Unit for Computed Tomography and Advanced Molecular Imaging at Philips based in the USA. Before this role, he was the Business Leader of image-guided Therapy for Philips North America and a member of the Philips North America Leadership Team and has served as Global Marketing Leader for Diagnostic X-Ray in Shanghai, China, in addition to various leadership positions in Europe.
"Mentice is at a key stage in its journey, and we are thrilled to welcome Frans Venker as our new CEO," said Magnus Nilsson, Chair of the Board. "His experience in our business areas and vision align perfectly with our strategic ambitions, and we are confident that he will succeed in using the progress made to take Mentice to the next stage in reaching its full potential. The board also wants to take the opportunity to again thank Göran Malmberg and reiterate its gratitude for Göran's vital contribution to the building of Mentice of today."
"It is an honor to take on this role at such a crucial time for the company. I look forward to leading the extraordinarily talented team at Mentice to deliver value for patients, customers, employees, and shareholders while building on the strong foundation already in place," said Frans Venker, looking forward to joining Mentice.
Venker is a Dutch citizen and holds a Master of Science degree in Applied Physics from the University of Groningen and an Executive MBA degree from the Rotterdam School of Management.
For more information, please contact:
Magnus Nilsson, Chair of the Board, Mentice
E-post: magnus.nilsson@mentice.com
Sweden Mobile +46 (0) 708 22 80 61
About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com
Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB
This information is information that Mentice is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-11-28 20:15 CET.
Image Attachments
Frans
